European governments see manufacturing as a vital next step toward developing a robust local biotech industry—and an essential fortification to protect their investments in the…
With commercialization of academic research slowly rising, debate is brewing over whether spinning off young companies can become too much of a good thing. With…
Cash awards have persuaded 25 promising scientists to settle in Europe, but there still remain other barriers to fostering bioentrepreneurs on the continent. On 26…
While European biotechnology in 2003 witnessed its first-ever year of declining revenues, in Switserland the sector showed surprising growth. According to the first Swiss Biotech…
Costly language translations required for filing patent applications in Europe burden the limited budgets of biotech companies. Biotech patent applications in Europe have grown dramatically…
A new report shows that attempts by the Dutch government to grow its biotech sector have produced fresh start-ups. But will they survive? According to…